全文获取类型
收费全文 | 2653篇 |
免费 | 163篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 41篇 |
妇产科学 | 46篇 |
基础医学 | 393篇 |
口腔科学 | 20篇 |
临床医学 | 166篇 |
内科学 | 854篇 |
皮肤病学 | 18篇 |
神经病学 | 260篇 |
特种医学 | 65篇 |
外科学 | 404篇 |
综合类 | 3篇 |
预防医学 | 46篇 |
眼科学 | 13篇 |
药学 | 83篇 |
中国医学 | 3篇 |
肿瘤学 | 419篇 |
出版年
2023年 | 18篇 |
2022年 | 21篇 |
2021年 | 54篇 |
2020年 | 25篇 |
2019年 | 41篇 |
2018年 | 52篇 |
2017年 | 47篇 |
2016年 | 49篇 |
2015年 | 66篇 |
2014年 | 95篇 |
2013年 | 110篇 |
2012年 | 183篇 |
2011年 | 233篇 |
2010年 | 113篇 |
2009年 | 103篇 |
2008年 | 210篇 |
2007年 | 152篇 |
2006年 | 154篇 |
2005年 | 178篇 |
2004年 | 160篇 |
2003年 | 134篇 |
2002年 | 173篇 |
2001年 | 29篇 |
2000年 | 21篇 |
1999年 | 29篇 |
1998年 | 52篇 |
1997年 | 42篇 |
1996年 | 41篇 |
1995年 | 43篇 |
1994年 | 30篇 |
1993年 | 13篇 |
1992年 | 20篇 |
1991年 | 14篇 |
1990年 | 19篇 |
1989年 | 19篇 |
1988年 | 14篇 |
1987年 | 12篇 |
1986年 | 7篇 |
1985年 | 6篇 |
1984年 | 8篇 |
1983年 | 6篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1980年 | 3篇 |
1979年 | 8篇 |
1978年 | 4篇 |
1977年 | 9篇 |
1973年 | 2篇 |
1970年 | 2篇 |
1968年 | 2篇 |
排序方式: 共有2849条查询结果,搜索用时 15 毫秒
61.
Junki Mizusawa Akira Fukutomi Hiroshi Katayama Hiroshi Ishii Tatsuya Ioka Takuji Okusaka Hideki Ueno Makoto Ueno Masafumi Ikeda Nobumasa Mizuno Masato Ozaka Haruhiko Fukuda Junji Furuse 《Pancreatology》2018,18(7):841-845
Gemcitabine is one of the standard treatments for locally advanced pancreatic cancer. Recent studies on metastatic pancreatic cancer have shown that combination chemotherapy with oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) and gemcitabine plus nab-paclitaxel (GnP) prolonged the overall survival compared with gemcitabine alone. To select the most promising chemotherapy, a randomized phase II selection design trial was started in July 2016 to compare between modified FOLFIRINOX and GnP for patients with locally advanced pancreatic cancer. A total of 124 patients will be enrolled from 36 Japanese institutions within 2.5 years. The primary endpoint is the proportion of 1-year overall survival, and secondary endpoints are progression-free survival, distant metastasis-free survival, response rate in patients with target lesions, CA19-9 response, adverse events, treatment-related death, early death, grade 4 non-hematological toxicity, and dose intensity. This trial has been registered with the UMIN Clinical Trials Registry [http://www.umin.ac.jp/ctr/index.htm], and the registration number is UMIN000023143. 相似文献
62.
63.
Kei Shimizu Kazuhito Funai Haruhiko Sugimura Keigo Sekihara Akikazu Kawase Norihiko Shiiya 《Pathology international》2013,63(4):201-205
The present study investigates whether lymphatic vessel invasion (LVI) detected by D2‐40 staining is a prognostic factor for stage I adenocarcinoma of the lung. We retrospectively reviewed 124 patients who underwent complete resection for stage I adenocarcinoma of the lung from January 1983 to June 2003. LVI was microscopically evaluated using D2‐40 immunostaining. The median follow‐up was 71 months. The LVI positive rate was 37%. The 5‐year cancer‐specific survival rates of the D2‐40 positive LVI and negative groups were 88.8% and 84.3%, respectively (P = 0.630). The stage I lung adenocarcinoma patients who were determined to be LVI positive based on D2‐40 immunostaining did not have a significantly poorer prognosis than the LVI negative cases. Thus, lymphatic microinvasion may not be a prognostic indicator in early lung cancer, although advanced LVI does appear to correlate with survival. It is therefore unnecessary to use D2‐40 immunostaining to diagnose LVI in practical settings, and Hematoxylin‐Eosin and Elastica van Gieson staining should continue to be used to predict the prognosis of patients with stage I lung adenocarcinoma. 相似文献
64.
Tetsuya Isaka Tomoyuki Yokose Hiroyuki Ito Kota Washimi Naoko Imamura Masato Watanabe Kentaro Imai Teppei Nishii Kouzo Yamada Haruhiko Nakayama Munetaka Masuda 《Pathology international》2013,63(12):615-618
Solitary pulmonary capillary hemangioma (SPCH) is a rare benign lung tumor that must be distinguished from small and early lung cancers. Here, we report a case of SPCH for which we performed frozen section diagnosis. The patient was a 55‐year‐old Japanese woman. Five years before the operation, mixed ground‐glass opacity was detected by computed tomography in the left posterior basal segment of the lower lobe (S10). Because the interior tumor density of the ground‐glass opacity increased slightly, video‐assisted thoracic surgery wedge resection was performed. Frozen section diagnosis revealed a benign tumor without proliferation of atypical epithelial cells. The tumor had narrow alveolar lumens, thickened alveolar septa and a clear boundary separating it from normal lung tissue. The proliferated lumens varied in size and were lined with single layers of flat cells. After the operation, immunohistochemical staining of a paraffin section revealed that the thickened alveolar septa resulted from the proliferation of capillary vessels, the flat cells of which were positive for CD31 and CD34 and negative for podoplanin; the tumor was diagnosed as SPCH. Here, we discuss the pathological features of SPCH on frozen sections with reference to this case and review previous related reports. 相似文献
65.
Takao NOZAKI Haruhiko SATO Tomohiro YAMAZOE Hiroki NAMBA 《Neurologia medico-chirurgica》2015,55(1):86-88
We report the case of a 58-year-old woman with low-grade astrocytoma, who developed massive intracranial hemorrhage as the first presentation of this disease, and become comatose and subsequently underwent an emergency craniotomy. A small amount of tumor-like tissue was observed on the wall of the hematoma cavity. Histological analysis of the resected specimen indicated diffuse astrocytoma [World Health Organization (WHO) grade II]. The patient was discharged without neurological deficits 2 weeks after the operation. A non-enhanced tumor-like nodule was observed on magnetic resonance imaging 3 months after the operation, which was monitored carefully but was not treated by adjuvant therapy. The tumor grew gradually, and a second operation was performed 3 years after the first, in which the tumor was completely resected. Histological analysis of the resected specimen again indicated diffuse astrocytoma (WHO grade II). Although rare, brain tumors, including low-grade astrocytoma, should be considered a possible cause of subcortical hemorrhage in patients without risk factors for intracranial hemorrhage. 相似文献
66.
67.
Effects of Inducers and Epoxide Hydrase on the Metabolism of Benzo[a]pyrene by Liver Microsomes and a Reconstituted System: Analysis by High Pressure Liquid Chromatography 总被引:2,自引:8,他引:2
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Gerald Holder Haruhiko Yagi Patrick Dansette Donald M. Jerina W. Levin Anthony Y. H. Lu A. H. Conney 《Proceedings of the National Academy of Sciences of the United States of America》1974,71(11):4356-4360
The mobilities of 24 potential metabolites of benzo[a]pyrene were examined with high pressure liquid chromatography. Twelve phenols, five quinones, four dihydrodiols, and three oxides were studied. The chromatographic procedure employed allowed the separation and quantitation of benzopyrene metabolites into three major groups consisting of phenols, quinones, and dihydrodiols. Two of the benzopyrene oxides were unstable during chromatography, whereas the third oxide was more stable and chromatographed in the quinone fraction.Treatment of rats with phenobarbital or 3-methylcholanthrene enhanced the metabolism of benzopyrene by liver microsomes and altered the relative amounts of the various metabolites formed. In the absence of epoxide hydrase (EC 4.2.1.63), benzopyrene was metabolized primarily to phenols and quinones but was not appreciably metabolized to dihydrodiols by a solubilized, reconstituted cytochrome P-448 monooxygenase system. Addition of partially purified epoxide hydrase resulted in the formation of benzopyrene dihydrodiols with a concomitant decrease in the formation of phenolic metabolites, indicating that benzopyrene undergoes metabolism via arene oxides that are precursors for dihydrodiols and phenols. 相似文献
68.
Toshihiro Tamano Haruhiko Yoshida Yukio Kuronuma Takashi Harada 《Journal of gastroenterology》1995,30(1):74-78
The importance of renal γ-glutamyltransferase activity in the hepatic utilization of exogenous glutathione (GSH) was evaluated by injecting GSH (1.67mmol/kg body wt) i.v. into bilaterally nephrectomized and sham-operated Sprague-Dawley rats in which endogenous hepatic GSH had been decreased (0.20±0.01μmol/g liver vs 5.87±0.26μmol/g liver in normal controls, mean±SD) by diethylmaleate (0.5 ml/kg body wt, i.p.). Hepatic GSH concentration 60 min after GSH administration was lower in the nephrectomized than in the sham-operated rats (0.87 ±0.25μol/g liver vs 3.08±0.81μmol/g liver,P<0.001), while plasma GSH concentration was higher in the former (4.61±1.07 mM vs 0.11±0.06 mM,P<0.001). In rats with intact kidneys which had been given a γ-glutamyltransferase inhibitor (acivicin, 25 (μmol/kg body wt i.v.) prior to GSH administration, the hepatic GSH concentrations (1.11±0.49μmol/g liver) were comparable to those obtained in the nephrectomized rats. When N-acetylcysteine (1.67 mmol/ kg body wt, i.v.) was administered instead of GSH, the hepatic GSH concentrations were similar in nephrectomized and sham-operated rats (1.54±0.23μmol/g liver vs 2.22±0.58μmol/g liver, NS). The γ-glutamyltransferase activity was much higher in the kidney than in the liver (4460±830IU/kg body wt vs 14±7IU/kg body wt). These results indicate that the kidney plays an essential role in the hepatic utilization of exogenous GSH through its high γ-glutamyltransferase activity. 相似文献
69.
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma 总被引:35,自引:0,他引:35
Shiina S Teratani T Obi S Sato S Tateishi R Fujishima T Ishikawa T Koike Y Yoshida H Kawabe T Omata M 《Gastroenterology》2005,129(1):122-130
BACKGROUND & AIMS: Percutaneous radiofrequency ablation is a recently introduced treatment for hepatocellular carcinoma, whereas ethanol injection is now a standard therapy. We compared their long-term outcomes. METHODS: Two hundred thirty-two patients with hepatocellular carcinoma who had 3 or fewer lesions, each 3 cm or less in diameter, and liver function of Child-Pugh class A or B were entered onto a randomized controlled trial. The primary end point was survival, and the secondary end points were overall recurrence and local tumor progression. RESULTS: One hundred eighteen patients were assigned to radiofrequency ablation and 114 to ethanol injection. The number of treatment sessions was smaller (2.1 times vs 6.4 times, respectively, P < .0001) and the length of hospitalization was shorter (10.8 days vs 26.1 days, respectively, P < .0001) in radiofrequency ablation than in ethanol injection. Four-year survival rate was 74% (95% CI: 65%-84%) in radiofrequency ablation and 57% (95% CI: 45%-71%) in ethanol injection. Radiofrequency ablation had a 46% smaller risk of death (adjusted relative risk, 0.54 [95% CI: 0.33-0.89], P = .02), a 43% smaller risk of overall recurrence (adjusted relative risk 0.57 [95% CI: 0.41-0.80], P = .0009), and an 88% smaller risk of local tumor progression (relative risk, 0.12 [95% CI: 0.03-0.55], P = .006) than ethanol injection. The incidence of adverse events was not different between the 2 therapies. CONCLUSIONS: Judging from higher survival but similar adverse events, radiofrequency ablation is superior to ethanol injection for small hepatocellular carcinoma. 相似文献
70.
Hiroshi Mukae Takeshi Kaneko Yasushi Obase Masaharu Shinkai Toshio Katsunuma Kiyoshi Takeyama Jiro Terada Akio Niimi Hiroto Matsuse Kazuhiro Yatera Yoshihiro Yamamoto Arata Azuma Hirokazu Arakawa Takashi Iwanaga Haruhiko Ogawa Kiyoyasu Kurahashi Yasuhiro Gon Hirokazu Sakamoto Jun Tamaoki 《Respiratory investigation》2021,59(3):270-290
Cough and sputum are common complaints at outpatient visits. In this digest version, we provide a general overview of these two symptoms and discuss the management of acute (up to three weeks) and prolonged/chronic cough (longer than three weeks). Flowcharts are provided, along with a step-by-step explanation of their diagnosis and management. Most cases of acute cough are due to an infection. In chronic respiratory illness, a cough could be a symptom of a respiratory infection such as pulmonary tuberculosis, malignancy such as a pulmonary tumor, asthma, chronic obstructive pulmonary disease, chronic bronchitis, bronchiectasis, drug-induced lung injury, heart failure, nasal sinus disease, sinobronchial syndrome, eosinophilic sinusitis, cough variant asthma (CVA), atopic cough, chronic laryngeal allergy, gastroesophageal reflux (GER), and post-infectious cough. Antibiotics should not be prescribed for over-peak cough but can be considered for atypical infections. The exploration of a single/major cause is recommended for persistent/chronic cough. When sputum is present, a sputum smear/culture (general bacteria, mycobacteria), cytology, cell differentiation, chest computed tomography (CT), and sinus X-ray or CT should be performed. There are two types of rhinosinusitis. Conventional sinusitis and eosinophilic rhinosinusitis present primarily with neutrophilic inflammation and eosinophilic inflammation, respectively. The most common causes of dry cough include CVA, atopic cough/laryngeal allergy (chronic), GER, and post-infectious cough. In the last chapter, future challenges and perspectives are discussed. We hope that the clarification of the pathology of cough hypersensitivity syndrome will lead to further development of “pathology-specific non-specific therapeutic drugs” and provide benefits to patients with chronic refractory cough. 相似文献